Breaking News Instant updates and real-time market news.

VG

Vonage

$12.75 /

+0.36 (+2.91%)

07:15
08/06/20
08/06
07:15
08/06/20
07:15

Vonage reports Q2 adj. EPS 4c, consensus 4c

Reports Q2 revenue $311M, consensus $296.54M. "We executed well in the second quarter and delivered strong financial results," said Rory Read, Chief Executive Officer. "Business segment service revenues grew 18% year over year, driven by increasing demand for our Vonage Communications Platform. API Platform revenues grew 32%, with 163% year-over-year growth in high-value API services, an area where we will continue to invest to support future growth. API Platform revenue now accounts for 47% of our Business revenues up from 41% a year ago. Our results in unified communications and contact center applications grew 7%, in line with expectations, despite COVID-19 headwinds. And, we continue to see momentum with larger customers, signing 11 new seven-figure total contract value deals. Going forward, we have more work to do and are building a highly-scalable streamlined go-to-market machine for our Applications products. We will focus on those customer segments where our products best fit, and where we create the most value and capture a disproportionate share of the market."

  • 06

    Aug

VG Vonage
$12.75 /

+0.36 (+2.91%)

07/27/20 Rosenblatt
Vonage initiated with a Neutral at Rosenblatt
06/30/20 Stephens
Agora IPO spotlights undervaluing of Vonage's API growth, says Stephens
06/09/20
Fly Intel: Top five analyst downgrades
06/08/20 Jefferies
Vonage downgraded to Hold from Buy at Jefferies

TODAY'S FREE FLY STORIES

General news
30-Yr Bond Announcement CUSIP Number data reported » 11:13
10/01/20
10/01
11:13
10/01/20
11:13

30-Yr Bond Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
30-Yr Bond Announcement Offering Amount data reported » 11:13
10/01/20
10/01
11:13
10/01/20
11:13

30-Yr Bond Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
10-Yr Note Announcement CUSIP Number data reported » 11:13
10/01/20
10/01
11:13
10/01/20
11:13

10-Yr Note Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
10-Yr Note Announcement Offering Amount data reported » 11:13
10/01/20
10/01
11:13
10/01/20
11:13

10-Yr Note Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
6-Month Bill Announcement Offering Amount data reported » 11:13
10/01/20
10/01
11:13
10/01/20
11:13

6-Month Bill Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
3-Month Bill Announcement Offering Amount data reported » 11:13
10/01/20
10/01
11:13
10/01/20
11:13

3-Month Bill Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
CareDx entrenched deeper into transplants with Palmetto LCD, says Piper » 11:07
10/01/20
10/01
11:07
10/01/20
11:07
CDNA

CareDx

$41.38 /

+3.35 (+8.81%)

Palmetto issued a final…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDNA CareDx
$41.38 /

+3.35 (+8.81%)

CDNA CareDx
$41.38 /

+3.35 (+8.81%)

08:26 Today Craig-Hallum
CareDx may receive HeartCare Medicare reimbursement, says Craig-Hallum
08/06/20 BTIG
CareDx price target raised to $45 from $40 at BTIG
08/05/20 H.C. Wainwright
CareDx price target raised to $40 from $37 at H.C. Wainwright
06/29/20 Piper Sandler
CareDx a top pick in diagnostics at Piper Sandler
CDNA CareDx
$41.38 /

+3.35 (+8.81%)

  • 11
    Jun
Options
Rocket Companies call volume above normal and directionally bullish » 11:05
10/01/20
10/01
11:05
10/01/20
11:05
RKT

Rocket Companies

$21.24 /

+1.315 (+6.60%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

09/25/20 Susquehanna
Rocket Companies upgraded to Neutral on valuation at Susquehanna
09/25/20 Susquehanna
Rocket Companies upgraded to Neutral from Negative at Susquehanna
09/10/20 Wedbush
Rocket Companies initiated with a Neutral, $24 price target at Wedbush
09/09/20 Wedbush
Rocket Companies initiated with a Neutral at Wedbush
RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

  • 06
    Aug
RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

Periodicals
Celsius Holdings sinks following short report from 'The Bear Cave" » 11:02
10/01/20
10/01
11:02
10/01/20
11:02
CELH

Celsius Holdings

$23.91 /

+1.16 (+5.10%)

Shares of Celsius…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CELH Celsius Holdings
$23.91 /

+1.16 (+5.10%)

CELH Celsius Holdings
$23.91 /

+1.16 (+5.10%)

08/07/20 Ladenburg
Celsius Holdings price target raised to $23.50 from $11.75 at Ladenburg
08/06/20 Roth Capital
Celsius Holdings price target raised to $25 from $14.50 at Roth Capital
07/28/20 B. Riley FBR
Celsius Holdings price target raised to $17 from $11.50 at B. Riley FBR
06/24/20 Maxim
Celsius Holdings price target raised to $15 from $12 at Maxim
CELH Celsius Holdings
$23.91 /

+1.16 (+5.10%)

Recommendations
Solaria price target raised to EUR 18 from EUR 11 at RBC Capital » 11:02
10/01/20
10/01
11:02
10/01/20
11:02
SEYMF

Solaria

$0.00 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
The U.S. construction spending report beat estimates » 11:00
10/01/20
10/01
11:00
10/01/20
11:00

The U.S. construction…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Chardan boosts Solid Biosciences target 250% to $12.50 from $5 » 10:55
10/01/20
10/01
10:55
10/01/20
10:55
SLDB

Solid Biosciences

$4.42 /

+2.39 (+117.73%)

Chardan analyst Gbola…

Chardan analyst Gbola Amusa raised the firm's price target on Solid Biosciences to $12.50 from $5 and keeps a Buy rating on the shares after the FDA lifted the clinical hold on the Phase I/II IGNITE DMD trial of AAV9-based gene therapy SGT-001 in Duchenne muscular dystrophy. Today's news is an "important positive" given that manufacturing constraints in the space leave an opportunity for Solid, and the view from many in the market that SGT-001 may not return to the clinic, Amusa tells investors in a research note. Duchenne muscular dystrophy is a "vast opportunity" for gene therapies, and one that could take Solid "significantly past" the new price target with progress, adds the analyst. The stock in morning trading is up 125% to $4.56.

ShowHide Related Items >><<
SLDB Solid Biosciences
$4.42 /

+2.39 (+117.73%)

SLDB Solid Biosciences
$4.42 /

+2.39 (+117.73%)

10:47 Today Chardan
Solid Biosciences price target raised to $12.50 from $5 at Chardan
07/28/20 SVB Leerink
Solid Biosciences downgraded to Market Perform at SVB Leerink
07/28/20 SVB Leerink
Solid Biosciences downgraded to Market Perform from Outperform at SVB Leerink
05/08/20 Nomura Instinet
Solid Biosciences price target lowered to $6 from $10 at Nomura Instinet
Options
AbbVie put volume heavy and directionally bearish » 10:55
10/01/20
10/01
10:55
10/01/20
10:55
ABBV

AbbVie

$87.65 /

+0.13 (+0.15%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$87.65 /

+0.13 (+0.15%)

ABBV AbbVie
$87.65 /

+0.13 (+0.15%)

09/29/20 Berenberg
AbbVie initiated with a Hold at Berenberg
09/28/20 Mizuho
Mizuho 'incrementally more bullish' on AbbVie integration of Allergan
09/02/20 Citi
AbbVie revenue potential offsets subpoena risk, says Citi
08/24/20 H.C. Wainwright
Galapagos downgraded to Neutral from Buy at H.C. Wainwright
ABBV AbbVie
$87.65 /

+0.13 (+0.15%)

ABBV AbbVie
$87.65 /

+0.13 (+0.15%)

ABBV AbbVie
$87.65 /

+0.13 (+0.15%)

Conference/Events
Federal Reserve Bank of New York to hold a virtual conference » 10:55
10/01/20
10/01
10:55
10/01/20
10:55
UBS

UBS

$11.17 /

+0.005 (+0.04%)

, GS

Goldman Sachs

$200.10 /

-1.01 (-0.50%)

2nd New York Fed Research…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBS UBS
$11.17 /

+0.005 (+0.04%)

GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

UBS UBS
$11.17 /

+0.005 (+0.04%)

07/24/20 Morgan Stanley
UBS price target raised to CHF 12 from CHF 11 at Morgan Stanley
07/23/20 Oddo BHF
UBS upgraded to Neutral from Reduce at Oddo BHF
07/22/20 Credit Suisse
UBS price target raised to CHF 14.50 from CHF 14 at Credit Suisse
07/22/20 RBC Capital
UBS price target raised to CHF 12 from CHF 11 at RBC Capital
GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

09/30/20 BofA
Goldman Sachs added to US 1 List, Citi removed at BofA
09/23/20 UBS
Goldman Sachs upgraded to Buy from Neutral at UBS
08/06/20 Piper Sandler
Now is the time to buy Goldman Sachs, says Piper Sandler
07/20/20 Berenberg
Goldman Sachs price target raised to $200 from $160 at Berenberg
UBS UBS
$11.17 /

+0.005 (+0.04%)

GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

UBS UBS
$11.17 /

+0.005 (+0.04%)

GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

UBS UBS
$11.17 /

+0.005 (+0.04%)

GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

Conference/Events
Federal Reserve Bank of New York participates in a virtual conference » 10:55
10/01/20
10/01
10:55
10/01/20
10:55

New York Federal Reserve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
BRP Group Inc (Class A Stock) trading resumes  10:54
10/01/20
10/01
10:54
10/01/20
10:54
BRP

BRP Group

$25.23 /

+0.32 (+1.28%)

 
ShowHide Related Items >><<
BRP BRP Group
$25.23 /

+0.32 (+1.28%)

BRP BRP Group
$25.23 /

+0.32 (+1.28%)

08/24/20 Canaccord
BRP Group price target raised to C$70 from C$60 at Canaccord
08/24/20 Raymond James
BRP Group price target raised to $25 from $18 at Raymond James
08/17/20 Jefferies
BRP Group price target raised to $21 from $12 at Jefferies
08/14/20 Keefe Bruyette
BRP Group price target raised to $24 from $19 at Keefe Bruyette
BRP BRP Group
$25.23 /

+0.32 (+1.28%)

  • 25
    Jun
  • 24
    Oct
BRP BRP Group
$25.23 /

+0.32 (+1.28%)

Recommendations
Chemtrade Logistics price target lowered to C$5.50 from C$6.50 at TD Securities » 10:53
10/01/20
10/01
10:53
10/01/20
10:53
CGIFF

Chemtrade Logistics

$0.00 /

+ (+0.00%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CGIFF Chemtrade Logistics
$0.00 /

+ (+0.00%)

08/27/20 TD Securities
Chemtrade Logistics financing reduces near-term risk, says TD Securities
08/27/20 BMO Capital
Chemtrade Logistics price target lowered to C$7.50 from C$7.75 at BMO Capital
08/17/20 CIBC
Chemtrade Logistics price target raised to C$7.50 from C$7 at CIBC
08/17/20 RBC Capital
Chemtrade Logistics price target raised to C$7 from C$6 at RBC Capital
Recommendations
MTY Food Group price target raised to C$32 from C$28 at TD Securities » 10:52
10/01/20
10/01
10:52
10/01/20
10:52
MTYFF

MTY Food Group

$0.00 /

+ (+0.00%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTYFF MTY Food Group
$0.00 /

+ (+0.00%)

09/23/20 National Bank
MTY Food Group price target raised to C$35 from C$32 at National Bank
07/13/20 Scotiabank
Scotiabank backs Sector Perform on MTY Food Group after 'solid' quarter
07/13/20 RBC Capital
MTY Food Group price target raised to C$27 from C$22 at RBC Capital
07/13/20 National Bank
MTY Food Group price target raised to C$32 from C$29 at National Bank
Recommendations
Suncor price target lowered to C$28 from C$30 at BMO Capital » 10:51
10/01/20
10/01
10:51
10/01/20
10:51
SU

Suncor

$11.85 /

-0.38 (-3.11%)

BMO Capital analyst Randy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SU Suncor
$11.85 /

-0.38 (-3.11%)

SU Suncor
$11.85 /

-0.38 (-3.11%)

09/30/20 Scotiabank
Suncor price target lowered to C$27 from C$30 at Scotiabank
09/18/20 TD Securities
Suncor price target lowered to C$31 from C$32 at TD Securities
09/09/20 RBC Capital
Suncor price target lowered to C$25 from C$28 at RBC Capital
09/09/20 TD Securities
Suncor price target lowered to C$32 from C$34 at TD Securities
SU Suncor
$11.85 /

-0.38 (-3.11%)

SU Suncor
$11.85 /

-0.38 (-3.11%)

Hot Stocks
Amag announces agreement to be acquired by Covis for $13.75 per share in cash » 10:50
10/01/20
10/01
10:50
10/01/20
10:50
AMAG

Amag Pharmaceuticals

$12.83 /

+3.41 (+36.20%)

Covis Group S.a r.l. and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMAG Amag Pharmaceuticals
$12.83 /

+3.41 (+36.20%)

AMAG Amag Pharmaceuticals
$12.83 /

+3.41 (+36.20%)

08/19/20 Truist
Amag Pharmaceuticals price target raised to $10 from $7 at Truist
08/18/20
Fly Intel: Top five analyst downgrades
08/18/20 Barclays
Barclays downgrades Amag Pharmaceuticals after 130% rally from lows
08/18/20 Barclays
Amag Pharmaceuticals downgraded to Equal Weight from Overweight at Barclays
AMAG Amag Pharmaceuticals
$12.83 /

+3.41 (+36.20%)

AMAG Amag Pharmaceuticals
$12.83 /

+3.41 (+36.20%)

General news
FX Action: USD-CAD » 10:50
10/01/20
10/01
10:50
10/01/20
10:50

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Ring Energy to host conference call » 10:50
10/01/20
10/01
10:50
10/01/20
10:50
REI

Ring Energy

$0.70 /

+0.0173 (+2.53%)

Management discusses the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REI Ring Energy
$0.70 /

+0.0173 (+2.53%)

REI Ring Energy
$0.70 /

+0.0173 (+2.53%)

09/16/20 Alliance Global Partners
Ring Energy assumed with a Neutral at Alliance Global Partners
08/11/20 Alliance Global Partners
Ring Energy asset sale overhang remains, says Alliance Global Partners
03/17/20 Alliance Global Partners
Ring Energy downgraded to Neutral from Buy at Alliance Global Partners
03/17/20 Johnson Rice
Ring Energy downgraded to Accumulate from Buy at Johnson Rice
REI Ring Energy
$0.70 /

+0.0173 (+2.53%)

Hot Stocks
BRP Group Inc (Class A Stock) trading halted, volatility trading pause  10:49
10/01/20
10/01
10:49
10/01/20
10:49
BRP

BRP Group

$24.93 /

+0.015 (+0.06%)

 
ShowHide Related Items >><<
BRP BRP Group
$24.93 /

+0.015 (+0.06%)

BRP BRP Group
$24.93 /

+0.015 (+0.06%)

08/24/20 Canaccord
BRP Group price target raised to C$70 from C$60 at Canaccord
08/24/20 Raymond James
BRP Group price target raised to $25 from $18 at Raymond James
08/17/20 Jefferies
BRP Group price target raised to $21 from $12 at Jefferies
08/14/20 Keefe Bruyette
BRP Group price target raised to $24 from $19 at Keefe Bruyette
BRP BRP Group
$24.93 /

+0.015 (+0.06%)

  • 25
    Jun
  • 24
    Oct
BRP BRP Group
$24.93 /

+0.015 (+0.06%)

Hot Stocks
Amag announces agreement to be acquired by Covis for $13.75 per share in cash  10:49
10/01/20
10/01
10:49
10/01/20
10:49
AMAG

Amag Pharmaceuticals

$12.85 /

+3.43 (+36.41%)

 
ShowHide Related Items >><<
AMAG Amag Pharmaceuticals
$12.85 /

+3.43 (+36.41%)

AMAG Amag Pharmaceuticals
$12.85 /

+3.43 (+36.41%)

08/19/20 Truist
Amag Pharmaceuticals price target raised to $10 from $7 at Truist
08/18/20
Fly Intel: Top five analyst downgrades
08/18/20 Barclays
Barclays downgrades Amag Pharmaceuticals after 130% rally from lows
08/18/20 Barclays
Amag Pharmaceuticals downgraded to Equal Weight from Overweight at Barclays
AMAG Amag Pharmaceuticals
$12.85 /

+3.43 (+36.41%)

AMAG Amag Pharmaceuticals
$12.85 /

+3.43 (+36.41%)

Recommendations
Sumo Group price target raised to 260 GBp from 230 GBp at Canaccord » 10:49
10/01/20
10/01
10:49
10/01/20
10:49
SUMGF

Sumo Group

$0.00 /

+ (+0.00%)

Canaccord analyst Steve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.